Systemic Inflammation Scores Predict the Activity of First-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

Cancer Invest. 2021 Jan;39(1):55-61. doi: 10.1080/07357907.2020.1863419. Epub 2020 Dec 22.

Abstract

Background: Systemic inflammation response (SIR)-related variables are controversial as predictive variables.

Methods: Patients with metastatic pancreatic adenocarcinoma (mPDAC) receiving chemotherapy were identified, three SIR-related variables and the relationships between each of them with overall survival (OS) were analysed.

Results: Of 129 patients receiving chemotherapy, 97 had metastases. A significant relationship between SIR and OS has been documented. Each of the SIR-related variables retained its independent prognostic role after multivariate analysis, whereas tri-linear peripheric blood-cell score (TRIS) appeared as the most reliable predictive parameter.

Conclusions: Among patients with mPDAC receiving chemotherapy, SIR is prognostic and could predict the effectiveness of chemotherapy.

Keywords: Metastatic pancreatic cancer; derived neutrophil-to-lymphocyte ratio; systemic inflammation response; trilinear peripheric blood cell score.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Inflammation / etiology*
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / mortality
  • Prognosis
  • Survival Analysis